Gene analysis techniques and susceptibility gene discovery in non-BRCA1/BRCA2 familial breast cancer
Breast cancer is the leading cause of cancer deaths in females worldwide occurring in both hereditary and sporadic forms. Women with inherited pathogenic mutations in the BRCA1 or BRCA2 genes have up to an 85% risk of developing breast cancer in their lifetimes. These patients are candidates for ris...
Saved in:
| Published in | Surgical oncology Vol. 24; no. 2; pp. 100 - 109 |
|---|---|
| Main Authors | , , , |
| Format | Journal Article |
| Language | English |
| Published |
Netherlands
Elsevier Ltd
01.06.2015
Elsevier Limited |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Breast cancer is the leading cause of cancer deaths in females worldwide occurring in both hereditary and sporadic forms. Women with inherited pathogenic mutations in the BRCA1 or BRCA2 genes have up to an 85% risk of developing breast cancer in their lifetimes. These patients are candidates for risk-reduction measures such as intensive radiological screening, prophylactic surgery or chemoprevention. However, only about 20% of familial breast cancer cases are attributed to mutations in BRCA1 and BRCA2, while a further 5–10% are attributed to mutations in other rare susceptibility genes such as TP53, STK11, PTEN, ATM and CHEK2. A multitude of genome wide association studies (GWAS) have been conducted confirming low-risk common variants associated with breast cancer in excess of 90 loci, which may contribute to a further 23% of the heritability.
We currently find ourselves in “the next generation”, with technologies offering deep sequencing at a fraction of the cost. Starting off primarily in a research setting, multi-gene panel testing is now utilized in the clinic to sequence multiple predisposing genes simultaneously (otherwise known as multi-gene panel testing). In this review, we focus on the hereditary breast cancer discoveries, techniques and the challenges we face in this complex disease, especially in the light of the vast amount of data we now have at hand. It has been 20 years since the first breast cancer susceptibility gene has been discovered and there has been substantial progress in unraveling the genetic component of the disease. However, hereditary breast cancer remains a challenging topic subject to common debate.
•Linkage analysis has discovered high-risk predisposing genes (BRCA1, BRCA2, TP53).•Moderate risk genes remain challenging in the context of a clinical setting.•More than 90 low-risk loci have been associated with breast cancer susceptibility.•Panel testing screens multiple genes at a fraction of the cost. |
|---|---|
| AbstractList | Breast cancer is the leading cause of cancer deaths in females worldwide occurring in both hereditary and sporadic forms. Women with inherited pathogenic mutations in theBRCA1orBRCA2genes have up to an 85% risk of developing breast cancer in their lifetimes. These patients are candidates for risk-reduction measures such as intensive radiological screening, prophylactic surgery or chemoprevention. However, only about 20% of familial breast cancer cases are attributed to mutations inBRCA1andBRCA2, while a further 5-10% are attributed to mutations in other rare susceptibility genes such asTP53,STK11,PTEN,ATMandCHEK2. A multitude of genome wide association studies (GWAS) have been conducted confirming low-risk common variants associated with breast cancer in excess of 90 loci, which may contribute to a further 23% of the heritability. We currently find ourselves in "the next generation", with technologies offering deep sequencing at a fraction of the cost. Starting off primarily in a research setting, multi-gene panel testing is now utilized in the clinic to sequence multiple predisposing genes simultaneously (otherwise known as multi-gene panel testing). In this review, we focus on the hereditary breast cancer discoveries, techniques and the challenges we face in this complex disease, especially in the light of the vast amount of data we now have at hand. It has been 20 years since the first breast cancer susceptibility gene has been discovered and there has been substantial progress in unraveling the genetic component of the disease. However, hereditary breast cancer remains a challenging topic subject to common debate. Abstract Breast cancer is the leading cause of cancer deaths in females worldwide occurring in both hereditary and sporadic forms. Women with inherited pathogenic mutations in the BRCA1 or BRCA2 genes have up to an 85% risk of developing breast cancer in their lifetimes. These patients are candidates for risk-reduction measures such as intensive radiological screening, prophylactic surgery or chemoprevention. However, only about 20% of familial breast cancer cases are attributed to mutations in BRCA1 and BRCA2 , while a further 5–10% are attributed to mutations in other rare susceptibility genes such as TP53 , STK11 , PTEN , ATM and CHEK2 . A multitude of genome wide association studies (GWAS) have been conducted confirming low-risk common variants associated with breast cancer in excess of 90 loci, which may contribute to a further 23% of the heritability. We currently find ourselves in “the next generation”, with technologies offering deep sequencing at a fraction of the cost. Starting off primarily in a research setting, multi-gene panel testing is now utilized in the clinic to sequence multiple predisposing genes simultaneously (otherwise known as multi-gene panel testing). In this review, we focus on the hereditary breast cancer discoveries, techniques and the challenges we face in this complex disease, especially in the light of the vast amount of data we now have at hand. It has been 20 years since the first breast cancer susceptibility gene has been discovered and there has been substantial progress in unraveling the genetic component of the disease. However, hereditary breast cancer remains a challenging topic subject to common debate. Breast cancer is the leading cause of cancer deaths in females worldwide occurring in both hereditary and sporadic forms. Women with inherited pathogenic mutations in the BRCA1 or BRCA2 genes have up to an 85% risk of developing breast cancer in their lifetimes. These patients are candidates for risk-reduction measures such as intensive radiological screening, prophylactic surgery or chemoprevention. However, only about 20% of familial breast cancer cases are attributed to mutations in BRCA1 and BRCA2, while a further 5–10% are attributed to mutations in other rare susceptibility genes such as TP53, STK11, PTEN, ATM and CHEK2. A multitude of genome wide association studies (GWAS) have been conducted confirming low-risk common variants associated with breast cancer in excess of 90 loci, which may contribute to a further 23% of the heritability. We currently find ourselves in “the next generation”, with technologies offering deep sequencing at a fraction of the cost. Starting off primarily in a research setting, multi-gene panel testing is now utilized in the clinic to sequence multiple predisposing genes simultaneously (otherwise known as multi-gene panel testing). In this review, we focus on the hereditary breast cancer discoveries, techniques and the challenges we face in this complex disease, especially in the light of the vast amount of data we now have at hand. It has been 20 years since the first breast cancer susceptibility gene has been discovered and there has been substantial progress in unraveling the genetic component of the disease. However, hereditary breast cancer remains a challenging topic subject to common debate. •Linkage analysis has discovered high-risk predisposing genes (BRCA1, BRCA2, TP53).•Moderate risk genes remain challenging in the context of a clinical setting.•More than 90 low-risk loci have been associated with breast cancer susceptibility.•Panel testing screens multiple genes at a fraction of the cost. Breast cancer is the leading cause of cancer deaths in females worldwide occurring in both hereditary and sporadic forms. Women with inherited pathogenic mutations in the BRCA1 or BRCA2 genes have up to an 85% risk of developing breast cancer in their lifetimes. These patients are candidates for risk-reduction measures such as intensive radiological screening, prophylactic surgery or chemoprevention. However, only about 20% of familial breast cancer cases are attributed to mutations in BRCA1 and BRCA2, while a further 5-10% are attributed to mutations in other rare susceptibility genes such as TP53, STK11, PTEN, ATM and CHEK2. A multitude of genome wide association studies (GWAS) have been conducted confirming low-risk common variants associated with breast cancer in excess of 90 loci, which may contribute to a further 23% of the heritability. We currently find ourselves in "the next generation", with technologies offering deep sequencing at a fraction of the cost. Starting off primarily in a research setting, multi-gene panel testing is now utilized in the clinic to sequence multiple predisposing genes simultaneously (otherwise known as multi-gene panel testing). In this review, we focus on the hereditary breast cancer discoveries, techniques and the challenges we face in this complex disease, especially in the light of the vast amount of data we now have at hand. It has been 20 years since the first breast cancer susceptibility gene has been discovered and there has been substantial progress in unraveling the genetic component of the disease. However, hereditary breast cancer remains a challenging topic subject to common debate.Breast cancer is the leading cause of cancer deaths in females worldwide occurring in both hereditary and sporadic forms. Women with inherited pathogenic mutations in the BRCA1 or BRCA2 genes have up to an 85% risk of developing breast cancer in their lifetimes. These patients are candidates for risk-reduction measures such as intensive radiological screening, prophylactic surgery or chemoprevention. However, only about 20% of familial breast cancer cases are attributed to mutations in BRCA1 and BRCA2, while a further 5-10% are attributed to mutations in other rare susceptibility genes such as TP53, STK11, PTEN, ATM and CHEK2. A multitude of genome wide association studies (GWAS) have been conducted confirming low-risk common variants associated with breast cancer in excess of 90 loci, which may contribute to a further 23% of the heritability. We currently find ourselves in "the next generation", with technologies offering deep sequencing at a fraction of the cost. Starting off primarily in a research setting, multi-gene panel testing is now utilized in the clinic to sequence multiple predisposing genes simultaneously (otherwise known as multi-gene panel testing). In this review, we focus on the hereditary breast cancer discoveries, techniques and the challenges we face in this complex disease, especially in the light of the vast amount of data we now have at hand. It has been 20 years since the first breast cancer susceptibility gene has been discovered and there has been substantial progress in unraveling the genetic component of the disease. However, hereditary breast cancer remains a challenging topic subject to common debate. Breast cancer is the leading cause of cancer deaths in females worldwide occurring in both hereditary and sporadic forms. Women with inherited pathogenic mutations in the BRCA1 or BRCA2 genes have up to an 85% risk of developing breast cancer in their lifetimes. These patients are candidates for risk-reduction measures such as intensive radiological screening, prophylactic surgery or chemoprevention. However, only about 20% of familial breast cancer cases are attributed to mutations in BRCA1 and BRCA2, while a further 5-10% are attributed to mutations in other rare susceptibility genes such as TP53, STK11, PTEN, ATM and CHEK2. A multitude of genome wide association studies (GWAS) have been conducted confirming low-risk common variants associated with breast cancer in excess of 90 loci, which may contribute to a further 23% of the heritability. We currently find ourselves in "the next generation", with technologies offering deep sequencing at a fraction of the cost. Starting off primarily in a research setting, multi-gene panel testing is now utilized in the clinic to sequence multiple predisposing genes simultaneously (otherwise known as multi-gene panel testing). In this review, we focus on the hereditary breast cancer discoveries, techniques and the challenges we face in this complex disease, especially in the light of the vast amount of data we now have at hand. It has been 20 years since the first breast cancer susceptibility gene has been discovered and there has been substantial progress in unraveling the genetic component of the disease. However, hereditary breast cancer remains a challenging topic subject to common debate. |
| Author | Aloraifi, Fatima Green, Andrew J. Boland, Michael R. Geraghty, James G. |
| Author_xml | – sequence: 1 givenname: Fatima surname: Aloraifi fullname: Aloraifi, Fatima email: faloraifi@rcsi.ie organization: Smurfit Institute of Genetics, Trinity College, Dublin 2, Ireland – sequence: 2 givenname: Michael R. orcidid: 0000-0002-6724-5630 surname: Boland fullname: Boland, Michael R. organization: Department of Breast Surgery, St Vincent's University Hospital, Dublin 4, Ireland – sequence: 3 givenname: Andrew J. surname: Green fullname: Green, Andrew J. organization: National Centre for Medical Genetics, Dublin 8, Ireland – sequence: 4 givenname: James G. surname: Geraghty fullname: Geraghty, James G. organization: Department of Breast Surgery, St Vincent's University Hospital, Dublin 4, Ireland |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25936246$$D View this record in MEDLINE/PubMed |
| BookMark | eNqVkt9qFDEUxoNU7Lb6BiID3ngz05NMdiYREepSq1AQ_HMdkswZzTqbWZNMYd7GZ_HJmmGrQkGKNycQft_JyfedE3LkR4-EPKVQUaDN2baKUxi9rRjQdQW8AqgfkBUVrSzrmsERWYFsoGw58GNyEuMWAJqW0UfkmK1l3TDerAheosdCez3M0cUiof3m3Y8JY77rijhFi_vkjBtcmouvC9u5aMdrDHPh_K-feajyzcfNOT1bKit6vcusHgoTUMdUWO0thsfkYa-HiE9uz1Py5e3F58278urD5fvN-VVpuRSppD3t-x4lCNGujaFQt01XW9lpLaxmtZaCCUG71ohWi8Y0sucCqOmMkbmw-pS8OPTdh3H5RFK7PC0Og_Y4TlHRFlhuziVk9PkddDtOIfuQqUasASjlTaae3VKT2WGn9sHtdJjVbwMzwA-ADWOMAfs_CAW15KS26pCTWnJSwFXOKcte3pFZl3Ryo09Bu-E-8euDGLOV1w6DitZh9rlzAW1S3ej-t4EdnHdWD99xxvjXCBWZAvVp2aNljWi2Bdh6Me_Vvxvc__4Nt6raJw |
| CitedBy_id | crossref_primary_10_1177_09622802211008945 crossref_primary_10_1016_j_sjbs_2020_05_047 crossref_primary_10_1186_s12920_019_0652_y crossref_primary_10_3390_cancers15133420 crossref_primary_10_1111_biom_13804 crossref_primary_10_1158_1055_9965_EPI_20_1193 crossref_primary_10_1007_s13193_016_0491_7 crossref_primary_10_1016_j_femme_2016_04_009 crossref_primary_10_1016_j_gofs_2023_03_001 crossref_primary_10_1007_s00439_017_1845_0 crossref_primary_10_3389_fonc_2018_00001 crossref_primary_10_1089_gtmb_2015_0339 crossref_primary_10_1039_D1RA05599B crossref_primary_10_3892_ol_2017_7578 crossref_primary_10_1007_s00438_018_1488_4 crossref_primary_10_1371_journal_pone_0170006 crossref_primary_10_1371_journal_pgen_1006029 crossref_primary_10_3390_ijms18020467 crossref_primary_10_1186_s13058_018_0964_4 crossref_primary_10_1007_s10549_016_4038_y crossref_primary_10_1186_s13104_022_06081_5 |
| Cites_doi | 10.3322/caac.21166 10.1126/science.7545954 10.1186/1471-2407-8-155 10.1073/pnas.97.17.9603 10.1371/journal.pone.0055681 10.1056/NEJM200007133430201 10.1016/j.cell.2010.03.032 10.1002/(SICI)1098-1004(1999)14:3<249::AID-HUMU8>3.0.CO;2-9 10.1038/ng1902 10.1038/nature11725 10.1007/s10549-008-0052-z 10.1186/bcr2832 10.1038/ng1959 10.1007/s10549-014-3078-4 10.1038/ng2075 10.1186/1471-2407-6-19 10.1016/S0140-6736(01)06524-2 10.1073/pnas.83.19.7353 10.1093/nar/gkq929 10.1038/nature05609 10.1086/421251 10.1056/NEJMoa1400382 10.1038/ng2064 10.1007/s10549-012-2057-x 10.1126/science.275.5308.1943 10.1111/j.1399-0004.2012.01859.x 10.1038/258427a0 10.1002/ijc.23168 10.1002/j.1460-2075.1995.tb00301.x 10.1016/S0027-5107(02)00029-5 10.1186/bcr1377 10.1038/ng.952 10.1038/nature09796 10.1002/cncr.24200 10.1126/science.1978757 10.1016/S0140-6736(10)60636-8 10.1038/ng.2007.53 10.1126/science.8091231 10.1126/science.1222794 10.1053/j.gastro.2004.03.014 10.1093/jnci/djq055 10.1073/pnas.1007983107 10.1016/0092-8674(92)90244-7 10.1016/S0092-8674(01)00304-X 10.1146/annurev.genom.9.081307.164339 10.1126/science.273.5281.1516 10.1001/jama.2010.119 10.1126/science.7824937 10.1038/nrg3117 10.1056/NEJM198705213162101 10.1016/j.ajhg.2011.11.029 10.1007/s10038-008-0285-z 10.1002/ijc.29210 10.1038/nature11017 10.1016/j.gde.2010.03.012 10.1136/jmg.40.12.e131 10.1073/pnas.74.12.5463 10.1007/s10549-014-2972-0 10.1038/nature03097 10.1186/1471-2407-7-83 10.1038/nrg3463 10.1093/aje/152.10.950 10.1038/322032a0 10.1038/nature08494 10.1371/journal.pone.0055734 10.1186/bcr1750 10.1038/ng1837 10.1038/ng.406 10.1242/jcs.114.20.3591 10.1097/00125817-200203000-00002 10.1093/carcin/bgi360 10.1186/1471-2407-6-48 10.1371/journal.pgen.1002894 10.1007/s10549-011-1704-y 10.1038/gim.2014.40 10.1136/jmg.2010.078113 10.1093/hmg/ddr229 10.1309/FDHX-L92R-BATQ-2GE0 10.1007/s10689-012-9540-8 10.1126/science.2270482 10.1038/ng1981 10.1186/1756-9966-32-95 10.1002/humu.10238 10.7326/0003-4819-71-4-747 10.1038/77139 10.1038/ng.499 10.1126/science.286.5449.2528 10.1086/302746 10.1093/jnci/djq088 10.1038/ejhg.2014.16 10.1002/cncr.26377 10.1038/sj.onc.1209873 10.1038/ng.3242 10.1038/ng.569 10.1158/0008-5472.CAN-13-2498 10.1186/bcr1336 10.1038/ng.646 10.1038/ng1071 10.1038/ng879 10.1038/nature05887 10.1038/sj.onc.1209877 10.1038/nature12213 10.1016/j.dnarep.2004.03.014 10.1038/ng0596-114 10.1126/science.1230062 10.1038/485S50a 10.1016/S1470-2045(11)70076-6 10.1073/pnas.93.8.3471 10.1101/gr.151464.112 10.1128/MCB.01384-09 10.1093/hmg/dds385 10.1126/science.1229259 10.1002/ijc.10214 10.1016/j.molcel.2006.05.022 10.1126/science.1228606 10.1016/S0959-8049(02)00498-7 10.1086/341943 |
| ContentType | Journal Article |
| Copyright | 2015 Elsevier Ltd Elsevier Ltd Copyright © 2015 Elsevier Ltd. All rights reserved. Copyright Elsevier Limited 2015 |
| Copyright_xml | – notice: 2015 Elsevier Ltd – notice: Elsevier Ltd – notice: Copyright © 2015 Elsevier Ltd. All rights reserved. – notice: Copyright Elsevier Limited 2015 |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QO 8FD FR3 K9. P64 7X8 |
| DOI | 10.1016/j.suronc.2015.04.003 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Biotechnology Research Abstracts Technology Research Database Engineering Research Database ProQuest Health & Medical Complete (Alumni) Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) Engineering Research Database Biotechnology Research Abstracts Technology Research Database Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
| DatabaseTitleList | ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1879-3320 |
| EndPage | 109 |
| ExternalDocumentID | 3701948321 25936246 10_1016_j_suronc_2015_04_003 S0960740415000250 1_s2_0_S0960740415000250 |
| Genre | Journal Article Review |
| GroupedDBID | --- --K --M .1- .FO .~1 0R~ 123 1B1 1P~ 1RT 1~. 1~5 29Q 4.4 457 4CK 4G. 53G 5VS 7-5 71M 8P~ 9JM AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AATTM AAXKI AAXUO AAYWO ABBQC ABJNI ABMAC ABMZM ABOCM ABWVN ABXDB ACDAQ ACGFS ACIEU ACIUM ACIWK ACPRK ACRLP ACRPL ADBBV ADEZE ADMUD ADNMO AEBSH AEIPS AEKER AEVXI AFJKZ AFRAH AFRHN AFTJW AFXIZ AGCQF AGHFR AGQPQ AGUBO AGYEJ AHHHB AHMBA AIEXJ AIIUN AIKHN AITUG AJRQY AJUYK ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV BPHCQ BVXVI CS3 EBS EFJIC EFKBS EJD EMOBN EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HED HMK HMO HVGLF HZ~ IHE J1W KOM M29 M41 MO0 N9A O-L O9- OAUVE OC~ OO- OZT P-8 P-9 P2P PC. PQQKQ PROAC Q38 R2- ROL RPZ SAE SCC SDF SDG SDP SEL SES SEW SPCBC SSH SSZ SV3 T5K UDS UHS WH7 WUQ Z5R ~G- 3V. 7X7 8FI AACTN AFCTW AFKRA AFKWA AJOXV AMFUW AZQEC BENPR FYUFA GUQSH M1P M2O RIG AAIAV ABLVK ABYKQ AJBFU EFLBG LCYCR AAYXX AGRNS CITATION CGR CUY CVF ECM EIF NPM 7QO 8FD FR3 K9. P64 7X8 |
| ID | FETCH-LOGICAL-c498t-1f1fffe908875bb10376d3c9daa8ca23a982881d7b87a86b69f4801bdbb9bdb23 |
| IEDL.DBID | .~1 |
| ISSN | 0960-7404 1879-3320 |
| IngestDate | Thu Jul 10 23:34:45 EDT 2025 Sat Aug 23 13:23:56 EDT 2025 Thu Apr 03 06:58:19 EDT 2025 Thu Apr 24 23:01:43 EDT 2025 Tue Jul 01 03:02:10 EDT 2025 Fri Feb 23 02:28:19 EST 2024 Sun Feb 23 10:18:54 EST 2025 Tue Aug 26 20:22:20 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2 |
| Keywords | Genetics Genetic predisposition to disease BRCA1 BRCA2 Sequence analysis Breast neoplasm |
| Language | English |
| License | Copyright © 2015 Elsevier Ltd. All rights reserved. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c498t-1f1fffe908875bb10376d3c9daa8ca23a982881d7b87a86b69f4801bdbb9bdb23 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 |
| ORCID | 0000-0002-6724-5630 |
| PMID | 25936246 |
| PQID | 1685001146 |
| PQPubID | 1216388 |
| PageCount | 10 |
| ParticipantIDs | proquest_miscellaneous_1702088490 proquest_journals_1685001146 pubmed_primary_25936246 crossref_primary_10_1016_j_suronc_2015_04_003 crossref_citationtrail_10_1016_j_suronc_2015_04_003 elsevier_sciencedirect_doi_10_1016_j_suronc_2015_04_003 elsevier_clinicalkeyesjournals_1_s2_0_S0960740415000250 elsevier_clinicalkey_doi_10_1016_j_suronc_2015_04_003 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2015-06-01 |
| PublicationDateYYYYMMDD | 2015-06-01 |
| PublicationDate_xml | – month: 06 year: 2015 text: 2015-06-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | Netherlands |
| PublicationPlace_xml | – name: Netherlands – name: Oxford |
| PublicationTitle | Surgical oncology |
| PublicationTitleAlternate | Surg Oncol |
| PublicationYear | 2015 |
| Publisher | Elsevier Ltd Elsevier Limited |
| Publisher_xml | – name: Elsevier Ltd – name: Elsevier Limited |
| References | Gilardini Montani, Prodosmo, Stagni, Merli, Monteonofrio, Gatti (bib74) 2013; 32 Huang, Hodis, Xu, Kryukov, Chin, Garraway (bib112) 2013; 339 Lawrence, Stojanov, Polak, Kryukov, Cibulskis, Sivachenko (bib119) 2013; 499 Swift, Reitnauer, Morrell, Chase (bib66) 1987; 316 Cantor, Bell, Ganesan, Kass, Drapkin, Grossman (bib81) 2001; 105 Wooster, Neuhausen, Mangion, Quirk (bib12) 1994; 265 Hirschhorn, Lohmueller (bib35) 2002; 4 Catucci, Milgrom, Kushnir, Laitman, Paluch-Shimon, Volorio (bib84) 2012; 11 Lewis, Flanagan, Marsh, Pupo, Mann, Spurdle (bib82) 2005; 7 Rehm (bib123) 2013; 14 Lim, Olschwang, Keller, Westerman, Menko, Boardman (bib64) 2004; 126 Blanco, Gutierrez-Enriquez, Santamarina, Montalban, Bonache, Balmaña (bib99) 2014; 147 LaDuca, Stuenkel, Dolinsky, Keiles, Tandy, Pesaran (bib124) 2014; 16 Nevanlinna, Bartek (bib78) 2006; 25 Morton (bib24) 1996; 93 Seal, Thompson, Renwick, Elliott, Kelly, Barfoot (bib68) 2006; 38 Yin, Tainsky, Bischoff, Strong, Wahl (bib54) 1992; 70 Gracia-Aznarez, Fernandez, Pita, Peterlongo, Dominguez, de la Hoya (bib115) 2013; 8 Maxmen (bib3) 2012; 485 Varghese, Easton (bib108) 2010; 20 Cox, Dunning, Garcia-Closas, Balasubramanian, Reed, Pooley (bib104) 2007; 39 Rutter, Smith, Dávila, Sigurdson, Giusti, Pineda (bib90) 2003; 22 Risch, Merikangas (bib101) 1996; 273 Wilson, Bateman, Hanson (bib58) 2010; 47 Royer-Pokora, Kunkel, Monaco, Goff, Newburger, Baehner (bib25) 1986; 322 LaDuca, Stuenkel, Dolinsky, Keiles, Tandy, Pesaran (bib19) 2014; 16 Ruark, Snape, Humburg, Loveday, Bajrami, Brough (bib46) 2013; 493 Sur, Hallikas, Vaharautio, Yan, Turunen, Enge (bib109) 2012 Stracker, Theunissen, Morales, Petrini (bib95) 2004; 3 (bib114) 2014 McClellan, King (bib33) 2010; 141 Rahman, Seal, Thompson, Kelly, Renwick, Elliott (bib26) 2007; 39 Heikkinen, Rapakko, Karppinen, Erkko, Knuutila, Lundán (bib70) 2006; 27 Lalloo, Evans (bib50) 2012; 82 (bib72) 2004; 74 Sunyaev (bib121) 2012; 21 Paynter, Chasman, Paré, Buring, Cook, Miletich (bib34) 2010; 303 Wright, Brown, Cole (bib110) 2010; 30 Lohmueller, Pearce, Pike, Lander, Hirschhorn (bib30) 2003; 33 Treangen, Salzberg (bib42) 2012; 13 Evans, Shenton, Woodward, Lalloo, Howell, Maher (bib14) 2008; 8 Michailidou, Beesley, Lindstrom, Canisius, Dennis, Lush (bib103) 2015; 47 Ng, Bigham, Buckingham, Hannibal, McMillin, Gildersleeve (bib44) 2010; 42 Castéra, Krieger, Rousselin, Legros, Baumann, Bruet (bib18) 2014; 22 Mann, Thorne, Balleine, Butow, Clarke, Edkins (bib16) 2006; 8 Stacey, Manolescu, Sulem, Rafnar, Gudmundsson, Gudjonsson (bib107) 2007; 39 Turnbull, Rahman (bib52) 2008; 9 Acs, Lawton, Rebbeck, LiVolsi, Zhang (bib61) 2001; 115 Kastan, Bartek (bib77) 2004; 432 Vahteristo, Bartkova, Eerola, Syrjäkoski, Ojala, Kilpivaara (bib28) 2002; 71 Hall, Reid, Burbidge, Pruss, Deffenbaugh, Frye (bib15) 2009; 115 Meijers-Heijboer, van den Ouweland, Klijn, Wasielewski, de Snoo, Oldenburg (bib80) 2008; 31 Siegel (bib2) 2013; 63 Pomerantz, Ahmadiyeh, Jia (bib37) 2009; 41 Zhu, Küster, Mann, Petrini, Lange (bib96) 2000; 25 Luo, Lei, Du, von Wachenfeldt, Kockum, Luthman (bib89) 2002; 98 Vahteristo, Yliannala, Tamminen, Eerola, Blomqvist, Nevanlinna (bib91) 2006; 6 Botstein, White, Skolnick, Davis (bib21) 1980; 32 Evans, Howell (bib7) 2007; 9 Nelen, Padberg, Peeters, Lin, van den Helm, Frants (bib48) 1996; 13 Stratton, Rahman (bib17) 2008; 40 Bell, Varley, Szydlo, Kang, Wahrer, Shannon (bib79) 1999; 286 Antoniou, Casadei, Heikkinen (bib93) 2014; 371 WHO (bib1) 2008 Taylor, Harnden, Arlett (bib75) 1975; 258 Rashid, Muhammad, Faisal, Amin, Hamann (bib100) 2014; 145 Li, Yen, Liaw, Podsypanina, Bose, Wang (bib63) 1997; 275 Meindl, Hellebrand, Wiek, Erven, Wappenschmidt, Niederacher (bib97) 2010; 42 Ahmed, Rahman (bib73) 2006; 25 Hilbers, Meijers, Laros, van Galen, Hoogerbrugge, Vasen (bib118) 2013; 8 Kainu, Juo, Desper, Schaffer, Gillanders, Rozenblum (bib67) 2000; 97 Mardis (bib40) 2011; 470 Overduin, Harvey, Bagby (bib59) 1995; 267 Venkitaraman (bib13) 2001; 114 Manolio, Collins, Cox, Goldstein, Hindorff, Hunter (bib32) 2009; 461 Broeks, Urbanus, Floore, Dahler, Klijn, Rutgers (bib65) 2000; 66 (bib6) 2001; 358 Frank, Hemminki, Meindl (bib85) 2007; 7 Bogdanova, Feshchenko, Schürmann, Waltes, Wieland, Hillemanns (bib94) 2008; 122 Horn, Figl, Rachakonda, Fischer, Sucker, Gast (bib111) 2013; 339 Caldeira, Prando, Quevedo, Neto, Rainho, Rogatto (bib62) 2006; 6 Travis, Reeves, Green, Bull, Tipper, Baker (bib9) 2010; 375 Park, Odefrey, Hammet, Giles, Baglietto, ABCFS (bib117) 2011; 130 Thompson, Doyle, Ryland, Rowley, Choong, Tothill (bib116) 2012; 8 Berx, Cleton-Jansen, Nollet, de Leeuw, van de Vijver, Cornelisse (bib49) 1995; 14 Hunter, Kraft, Jacobs, Cox, Yeager, Hankinson (bib106) 2007; 39 Morton (bib23) 1955; 7 Hall, Lee, Newman, Morrow (bib10) 1990; 250 Hemminki, Avizienyt, Roth, Avizienyte, Roth, Loukola (bib47) 1998; 114 Kuusisto, Bebel, Vihinen, Schleutker, Sallinen (bib88) 2011; 13 Sanger, Nicklen, Coulson (bib41) 1977; 74 Varshney, Lu, Gildea, Huang, Pei, Yang (bib122) 2013; 23 Strachan, Read (bib29) 1999 Malkin, Li, Strong, Fraumeni, Nelson, Kim (bib55) 1990; 250 Xia, Sheng, Nakanishi, Ohashi, Wu, Christ (bib92) 2006; 22 Papadopoulos, Kinde, Munari, Hruban, Schoenberg, Bivalacqua (bib113) 2013; 73 Guilford, Hopkins, Grady, Markowitz, Willis, Lynch (bib60) 1999; 14 Lichtenstein, Holm, Verkasalo, Iliadou, Kaprio, Koskenvuo (bib8) 2000 Jul 13; 343 Forbes, Bindal, Bamford, Cole, Kok, Beare (bib51) 2011; 39 Karppinen, Vuosku, Heikkinen, Allinen, Winqvist (bib87) 2003; 39 Snape, Ruark, Tarpey, Renwick, Turnbull, Seal (bib43) 2012; 134 Cao, Huang, Hu, Jones-Hughes, Coelho, Cooper (bib83) 2009; 115 Rivas, Beaudoin, Gardet, Stevens, Sharma, Zhang (bib38) 2011; 43 Pelttari, Heikkinen, Thompson, Kallioniemi, Schleutker, Holli (bib98) 2011; 20 Amir, Freedman, Seruga, Evans (bib4) 2010; 102 Renwick, Thompson, Seal, Kelly, Chagtai, Ahmed (bib27) 2006; 38 Li, Fraumeni (bib53) 1969; 71 Stephens, Tarpey, Davies, Van Loo, Greenman, Wedge (bib120) 2012; 486 Easton, Pooley, Dunning, Pharoah, Thompson, Ballinger (bib105) 2007; 447 Colditz, Rosner (bib5) 2000; 152 Miki, Swensen, Shattuck-Eidens, Futreal, Harshman, Tavtigian (bib11) 1994; 266 Maurano, Humbert, Rynes, Thurman, Haugen, Wang (bib36) 2012; 337 Ferlay, Soerjomataram, Dikshit, Eser, Mathers, Rebelo (bib125) 2015; 136 Walsh, Lee, Casadei, Thornton, Stray, Pennil (bib20) 2010; 107 Tuupanen, Turunen, Lehtonen, Hallikas, Vanharanta, Kivioja (bib39) 2009; 41 Liang, Shao, Deng, Mendonca, Stambrook, Tischfield (bib56) 2002; 502 Ng, Bigham, Buckingham, Bigham, Tabor, Dent (bib45) 2010; 42 Bernstein, Haile, Stovall, Boice, Shore, Langholz (bib76) 2010; 102 Lander, Botstein (bib22) 1986; 83 Visscher, Brown, McCarthy, Yang (bib31) 2012; 90 Melhem-Bertrandt, Bojadzieva, Ready, Obeid, Liu, Gutierrez-Barrera (bib57) 2012; 118 Guénard, Labrie, Ouellette, Joly Beauparlant, Simard, Durocher (bib86) 2008; 53 Zhang, Beeghly-Fadiel, Long, Zheng (bib102) 2011; 12 Heikkinen, Karppinen, Soini, Makinen, Winqvist (bib69) 2003; 40 Erkko, Xia, Nikkilä, Schleutker, Syrjäkoski, Mannermaa (bib71) 2007; 446 Catucci (10.1016/j.suronc.2015.04.003_bib84) 2012; 11 Cox (10.1016/j.suronc.2015.04.003_bib104) 2007; 39 Gracia-Aznarez (10.1016/j.suronc.2015.04.003_bib115) 2013; 8 Seal (10.1016/j.suronc.2015.04.003_bib68) 2006; 38 Huang (10.1016/j.suronc.2015.04.003_bib112) 2013; 339 Lawrence (10.1016/j.suronc.2015.04.003_bib119) 2013; 499 McClellan (10.1016/j.suronc.2015.04.003_bib33) 2010; 141 Rehm (10.1016/j.suronc.2015.04.003_bib123) 2013; 14 (10.1016/j.suronc.2015.04.003_bib6) 2001; 358 Visscher (10.1016/j.suronc.2015.04.003_bib31) 2012; 90 Antoniou (10.1016/j.suronc.2015.04.003_bib93) 2014; 371 Rashid (10.1016/j.suronc.2015.04.003_bib100) 2014; 145 Tuupanen (10.1016/j.suronc.2015.04.003_bib39) 2009; 41 Ng (10.1016/j.suronc.2015.04.003_bib44) 2010; 42 Papadopoulos (10.1016/j.suronc.2015.04.003_bib113) 2013; 73 Horn (10.1016/j.suronc.2015.04.003_bib111) 2013; 339 Colditz (10.1016/j.suronc.2015.04.003_bib5) 2000; 152 Zhu (10.1016/j.suronc.2015.04.003_bib96) 2000; 25 Renwick (10.1016/j.suronc.2015.04.003_bib27) 2006; 38 Venkitaraman (10.1016/j.suronc.2015.04.003_bib13) 2001; 114 Paynter (10.1016/j.suronc.2015.04.003_bib34) 2010; 303 Karppinen (10.1016/j.suronc.2015.04.003_bib87) 2003; 39 Strachan (10.1016/j.suronc.2015.04.003_bib29) 1999 Mardis (10.1016/j.suronc.2015.04.003_bib40) 2011; 470 Vahteristo (10.1016/j.suronc.2015.04.003_bib91) 2006; 6 Turnbull (10.1016/j.suronc.2015.04.003_bib52) 2008; 9 Stracker (10.1016/j.suronc.2015.04.003_bib95) 2004; 3 Bell (10.1016/j.suronc.2015.04.003_bib79) 1999; 286 Heikkinen (10.1016/j.suronc.2015.04.003_bib69) 2003; 40 LaDuca (10.1016/j.suronc.2015.04.003_bib19) 2014; 16 Frank (10.1016/j.suronc.2015.04.003_bib85) 2007; 7 Wright (10.1016/j.suronc.2015.04.003_bib110) 2010; 30 WHO (10.1016/j.suronc.2015.04.003_bib1) 2008 Stacey (10.1016/j.suronc.2015.04.003_bib107) 2007; 39 Manolio (10.1016/j.suronc.2015.04.003_bib32) 2009; 461 Michailidou (10.1016/j.suronc.2015.04.003_bib103) 2015; 47 Hirschhorn (10.1016/j.suronc.2015.04.003_bib35) 2002; 4 Erkko (10.1016/j.suronc.2015.04.003_bib71) 2007; 446 Sunyaev (10.1016/j.suronc.2015.04.003_bib121) 2012; 21 Stratton (10.1016/j.suronc.2015.04.003_bib17) 2008; 40 Ruark (10.1016/j.suronc.2015.04.003_bib46) 2013; 493 Amir (10.1016/j.suronc.2015.04.003_bib4) 2010; 102 Nevanlinna (10.1016/j.suronc.2015.04.003_bib78) 2006; 25 Gilardini Montani (10.1016/j.suronc.2015.04.003_bib74) 2013; 32 Miki (10.1016/j.suronc.2015.04.003_bib11) 1994; 266 Maxmen (10.1016/j.suronc.2015.04.003_bib3) 2012; 485 Berx (10.1016/j.suronc.2015.04.003_bib49) 1995; 14 Guilford (10.1016/j.suronc.2015.04.003_bib60) 1999; 14 Ng (10.1016/j.suronc.2015.04.003_bib45) 2010; 42 Rahman (10.1016/j.suronc.2015.04.003_bib26) 2007; 39 Wilson (10.1016/j.suronc.2015.04.003_bib58) 2010; 47 Vahteristo (10.1016/j.suronc.2015.04.003_bib28) 2002; 71 Acs (10.1016/j.suronc.2015.04.003_bib61) 2001; 115 Melhem-Bertrandt (10.1016/j.suronc.2015.04.003_bib57) 2012; 118 Mann (10.1016/j.suronc.2015.04.003_bib16) 2006; 8 Broeks (10.1016/j.suronc.2015.04.003_bib65) 2000; 66 Stephens (10.1016/j.suronc.2015.04.003_bib120) 2012; 486 Pomerantz (10.1016/j.suronc.2015.04.003_bib37) 2009; 41 Royer-Pokora (10.1016/j.suronc.2015.04.003_bib25) 1986; 322 Risch (10.1016/j.suronc.2015.04.003_bib101) 1996; 273 Castéra (10.1016/j.suronc.2015.04.003_bib18) 2014; 22 Kuusisto (10.1016/j.suronc.2015.04.003_bib88) 2011; 13 Ferlay (10.1016/j.suronc.2015.04.003_bib125) 2015; 136 Sur (10.1016/j.suronc.2015.04.003_bib109) 2012 Snape (10.1016/j.suronc.2015.04.003_bib43) 2012; 134 Cantor (10.1016/j.suronc.2015.04.003_bib81) 2001; 105 (10.1016/j.suronc.2015.04.003_bib114) 2014 Rutter (10.1016/j.suronc.2015.04.003_bib90) 2003; 22 Hemminki (10.1016/j.suronc.2015.04.003_bib47) 1998; 114 Rivas (10.1016/j.suronc.2015.04.003_bib38) 2011; 43 Evans (10.1016/j.suronc.2015.04.003_bib7) 2007; 9 Morton (10.1016/j.suronc.2015.04.003_bib23) 1955; 7 Yin (10.1016/j.suronc.2015.04.003_bib54) 1992; 70 Ahmed (10.1016/j.suronc.2015.04.003_bib73) 2006; 25 Guénard (10.1016/j.suronc.2015.04.003_bib86) 2008; 53 Luo (10.1016/j.suronc.2015.04.003_bib89) 2002; 98 Lalloo (10.1016/j.suronc.2015.04.003_bib50) 2012; 82 Hunter (10.1016/j.suronc.2015.04.003_bib106) 2007; 39 Cao (10.1016/j.suronc.2015.04.003_bib83) 2009; 115 Lichtenstein (10.1016/j.suronc.2015.04.003_bib8) 2000; 343 Morton (10.1016/j.suronc.2015.04.003_bib24) 1996; 93 Caldeira (10.1016/j.suronc.2015.04.003_bib62) 2006; 6 Varshney (10.1016/j.suronc.2015.04.003_bib122) 2013; 23 Wooster (10.1016/j.suronc.2015.04.003_bib12) 1994; 265 Bernstein (10.1016/j.suronc.2015.04.003_bib76) 2010; 102 Lander (10.1016/j.suronc.2015.04.003_bib22) 1986; 83 Zhang (10.1016/j.suronc.2015.04.003_bib102) 2011; 12 Lim (10.1016/j.suronc.2015.04.003_bib64) 2004; 126 (10.1016/j.suronc.2015.04.003_bib72) 2004; 74 Treangen (10.1016/j.suronc.2015.04.003_bib42) 2012; 13 Kastan (10.1016/j.suronc.2015.04.003_bib77) 2004; 432 Blanco (10.1016/j.suronc.2015.04.003_bib99) 2014; 147 Hilbers (10.1016/j.suronc.2015.04.003_bib118) 2013; 8 Lewis (10.1016/j.suronc.2015.04.003_bib82) 2005; 7 Li (10.1016/j.suronc.2015.04.003_bib63) 1997; 275 Meijers-Heijboer (10.1016/j.suronc.2015.04.003_bib80) 2008; 31 Siegel (10.1016/j.suronc.2015.04.003_bib2) 2013; 63 Swift (10.1016/j.suronc.2015.04.003_bib66) 1987; 316 Taylor (10.1016/j.suronc.2015.04.003_bib75) 1975; 258 Xia (10.1016/j.suronc.2015.04.003_bib92) 2006; 22 Thompson (10.1016/j.suronc.2015.04.003_bib116) 2012; 8 Forbes (10.1016/j.suronc.2015.04.003_bib51) 2011; 39 Pelttari (10.1016/j.suronc.2015.04.003_bib98) 2011; 20 Hall (10.1016/j.suronc.2015.04.003_bib10) 1990; 250 Overduin (10.1016/j.suronc.2015.04.003_bib59) 1995; 267 Kainu (10.1016/j.suronc.2015.04.003_bib67) 2000; 97 LaDuca (10.1016/j.suronc.2015.04.003_bib124) 2014; 16 Travis (10.1016/j.suronc.2015.04.003_bib9) 2010; 375 Liang (10.1016/j.suronc.2015.04.003_bib56) 2002; 502 Heikkinen (10.1016/j.suronc.2015.04.003_bib70) 2006; 27 Evans (10.1016/j.suronc.2015.04.003_bib14) 2008; 8 Botstein (10.1016/j.suronc.2015.04.003_bib21) 1980; 32 Maurano (10.1016/j.suronc.2015.04.003_bib36) 2012; 337 Varghese (10.1016/j.suronc.2015.04.003_bib108) 2010; 20 Nelen (10.1016/j.suronc.2015.04.003_bib48) 1996; 13 Li (10.1016/j.suronc.2015.04.003_bib53) 1969; 71 Hall (10.1016/j.suronc.2015.04.003_bib15) 2009; 115 Lohmueller (10.1016/j.suronc.2015.04.003_bib30) 2003; 33 Walsh (10.1016/j.suronc.2015.04.003_bib20) 2010; 107 Sanger (10.1016/j.suronc.2015.04.003_bib41) 1977; 74 Bogdanova (10.1016/j.suronc.2015.04.003_bib94) 2008; 122 Malkin (10.1016/j.suronc.2015.04.003_bib55) 1990; 250 Park (10.1016/j.suronc.2015.04.003_bib117) 2011; 130 Meindl (10.1016/j.suronc.2015.04.003_bib97) 2010; 42 Easton (10.1016/j.suronc.2015.04.003_bib105) 2007; 447 |
| References_xml | – volume: 14 start-page: 249 year: 1999 end-page: 255 ident: bib60 article-title: E-cadherin germline mutations define an inherited cancer syndrome dominated by diffuse gastric cancer publication-title: Hum Mutat – volume: 115 start-page: 85 year: 2001 end-page: 98 ident: bib61 article-title: Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications publication-title: Am J Clin Pathology – volume: 40 start-page: 1 year: 2003 end-page: 7 ident: bib69 article-title: Mutation screening of Mre11 complex genes: indication of RAD50 involvement in breast and ovarian cancer susceptibility publication-title: J Med Genet – volume: 25 start-page: 347 year: 2000 end-page: 352 ident: bib96 article-title: Cell-cycle-regulated association of RAD50/MRE11/NBS1 with TRF2 and human telomeres publication-title: Nat Genet – volume: 499 start-page: 214 year: 2013 end-page: 218 ident: bib119 article-title: Mutational heterogeneity in cancer and the search for new cancer-associated genes publication-title: Nature – volume: 31 start-page: 55 year: 2008 end-page: 59 ident: bib80 article-title: Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations publication-title: Nat Genet – volume: 447 start-page: 1087 year: 2007 end-page: 1093 ident: bib105 article-title: Genome-wide association study identifies novel breast cancer susceptibility loci publication-title: Nature – volume: 126 start-page: 1788 year: 2004 end-page: 1794 ident: bib64 article-title: Relative frequency and morphology of cancers in STK11 mutation carriers publication-title: Gastroenterology – volume: 322 start-page: 32 year: 1986 end-page: 38 ident: bib25 article-title: Cloning the gene for the inherited disorder chronic granulomatous disease on the basis of its chromosomal location publication-title: Nature – volume: 105 start-page: 149 year: 2001 end-page: 160 ident: bib81 article-title: BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function publication-title: Cell – volume: 41 start-page: 882 year: 2009 end-page: 884 ident: bib37 article-title: The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer publication-title: Nature – volume: 39 start-page: D945 year: 2011 end-page: D950 ident: bib51 article-title: COSMIC: mining complete cancer genomes in the catalogue of somatic mutations in cancer publication-title: Nucleic Acids Res – volume: 461 start-page: 747 year: 2009 end-page: 753 ident: bib32 article-title: Finding the missing heritability of complex diseases publication-title: Nature – volume: 134 start-page: 429 year: 2012 end-page: 433 ident: bib43 article-title: Predisposition gene identification in common cancers by exome sequencing: insights from familial breast cancer publication-title: Breast Cancer Res Treat – volume: 16 start-page: 830 year: 2014 end-page: 837 ident: bib124 article-title: Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2,000 patients publication-title: Genet Med – volume: 107 start-page: 12629 year: 2010 ident: bib20 article-title: Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencing publication-title: Proc Natl Acad Sci – volume: 432 start-page: 316 year: 2004 end-page: 323 ident: bib77 article-title: Cell-cycle checkpoints and cancer publication-title: Nature – volume: 13 start-page: 114 year: 1996 end-page: 116 ident: bib48 article-title: Localization of the gene for Cowden disease to chromosome 10q22-23 publication-title: Nat Genet – volume: 42 start-page: 410 year: 2010 end-page: 414 ident: bib97 article-title: Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene publication-title: Nat Genet – volume: 7 start-page: 83 year: 2007 ident: bib85 article-title: BRIP1 (BACH1) variants and familial breast cancer risk: a case-control study publication-title: BMC Cancer – volume: 250 start-page: 17 year: 1990 end-page: 22 ident: bib10 article-title: Linkage of early-onset familial breast cancer to chromosome 17q21 publication-title: Science – volume: 6 start-page: 48 year: 2006 ident: bib62 article-title: CDH1 promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer publication-title: BMC Cancer – volume: 316 start-page: 1289 year: 1987 end-page: 1294 ident: bib66 article-title: Breast and other cancers in families with ataxia-telangiectasia publication-title: N Engl J Med – volume: 118 start-page: 908 year: 2012 end-page: 913 ident: bib57 article-title: Early onset HER2-positive breast cancer is associated with germline TP53 mutations publication-title: Cancer – volume: 32 start-page: 95 year: 2013 ident: bib74 article-title: ATM-depletion in breast cancer cells confers sensitivity to PARP inhibition publication-title: J Exp Clin Cancer Res – volume: 33 start-page: 177 year: 2003 end-page: 182 ident: bib30 article-title: Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease publication-title: Nat Genet – volume: 265 start-page: 15 year: 1994 end-page: 17 ident: bib12 article-title: Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13 publication-title: Science – year: 1999 ident: bib29 article-title: Human molecular genetics – volume: 39 start-page: 165 year: 2007 end-page: 167 ident: bib26 article-title: PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene publication-title: Nat Genet – volume: 74 start-page: 1175 year: 2004 end-page: 1182 ident: bib72 article-title: CHEK2*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies publication-title: Am J Hum Genet – volume: 343 start-page: 78 year: 2000 Jul 13 end-page: 85 ident: bib8 article-title: Environmental and heritable factors in the causation of cancer—analyses of cohorts of twins from Sweden, Denmark, and Finland publication-title: N Engl J Med – volume: 145 start-page: 775 year: 2014 end-page: 784 ident: bib100 article-title: Deleterious RAD51C germline mutations rarely predispose to breast and ovarian cancer in Pakistan publication-title: Breast Cancer Res Treat – volume: 3 start-page: 845 year: 2004 end-page: 854 ident: bib95 article-title: The Mre11 complex and the metabolism of chromosome breaks: the importance of communicating and holding things together publication-title: DNA Repair – volume: 74 start-page: 5463 year: 1977 end-page: 5467 ident: bib41 article-title: DNA sequencing with chain-terminating inhibitors publication-title: Proc Natl Acad Sci USA – volume: 13 start-page: 36 year: 2012 end-page: 46 ident: bib42 article-title: Repetitive DNA and next-generation sequencing: computational challenges and solutions publication-title: Nat Rev Genet – volume: 23 start-page: 727 year: 2013 end-page: 735 ident: bib122 article-title: A large-scale zebrafish gene knockout resource for the genome-wide study of gene function publication-title: Genome Res – volume: 152 start-page: 950 year: 2000 end-page: 964 ident: bib5 article-title: Cumulative risk of breast cancer to age 70 years according to risk factor status: data from the Nurses' health Study publication-title: Am J Epidemiol – volume: 7 start-page: 277 year: 1955 end-page: 318 ident: bib23 article-title: Sequential tests for the detection of linkage publication-title: Am J Hum Genet – volume: 303 start-page: 631 year: 2010 end-page: 637 ident: bib34 article-title: Association between a literature-based genetic risk score and cardiovascular events in women publication-title: JAMA – volume: 358 start-page: 1389 year: 2001 end-page: 1399 ident: bib6 article-title: Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58 209 women with breast cancer and 101 986 women without the disease publication-title: Lancet – volume: 42 start-page: 790 year: 2010 end-page: 793 ident: bib44 article-title: Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome publication-title: Nat Genet – volume: 8 start-page: e55734 year: 2013 ident: bib118 article-title: Exome sequencing of germline DNA from non-BRCA1/2 familial breast cancer cases selected on the basis of aCGH tumor profiling publication-title: PloS One – volume: 93 start-page: 3471 year: 1996 end-page: 3476 ident: bib24 article-title: Logarithm of odds (lods) for linkage in complex inheritance publication-title: Proc Natl Acad Sci USA – volume: 102 start-page: 475 year: 2010 end-page: 483 ident: bib76 article-title: Radiation exposure, the ATM gene, and contralateral breast cancer in the women's environmental cancer and radiation epidemiology study publication-title: J Natl Cancer Inst – volume: 38 start-page: 1239 year: 2006 end-page: 1241 ident: bib68 article-title: Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles publication-title: Nat Genet – volume: 13 start-page: R20 year: 2011 ident: bib88 article-title: Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals publication-title: Breast Cancer Res Treat – volume: 73 start-page: 7162 year: 2013 end-page: 7167 ident: bib113 article-title: TERT promoter mutations occur early in urothelial neoplasia and are biomarkers of early disease and disease recurrence in urine publication-title: Cancer Res – volume: 130 start-page: 1043 year: 2011 end-page: 1049 ident: bib117 article-title: FAN1 variants identified in multiple-case early-onset breast cancer families via exome sequencing: no evidence for association with risk for breast cancer publication-title: Breast Cancer Res Treat – volume: 97 start-page: 9603 year: 2000 end-page: 9608 ident: bib67 article-title: Somatic deletions in hereditary breast cancers implicate 13q21 as a putative novel breast cancer susceptibility locus publication-title: PNAS – volume: 53 start-page: 579 year: 2008 end-page: 591 ident: bib86 article-title: Mutational analysis of the breast cancer susceptibility gene BRIP1/BACH1/FANCJ in high-risk non-BRCA1/BRCA2 breast cancer families publication-title: J Hum Genet – volume: 102 start-page: 680 year: 2010 end-page: 691 ident: bib4 article-title: Assessing women at high risk of breast cancer: a review of risk assessment models publication-title: J Natl Cancer Inst – volume: 115 start-page: 2222 year: 2009 end-page: 2233 ident: bib15 article-title: BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer publication-title: Cancer – volume: 446 start-page: 316 year: 2007 end-page: 319 ident: bib71 article-title: A recurrent mutation in PALB2 in Finnish cancer families publication-title: Nature – volume: 14 start-page: 6107 year: 1995 end-page: 6115 ident: bib49 article-title: E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers publication-title: EMBO J – volume: 9 start-page: 213 year: 2007 ident: bib7 article-title: Breast cancer risk-assessment models publication-title: Breast Cancer Res – volume: 11 start-page: 483 year: 2012 end-page: 491 ident: bib84 article-title: Germline mutations in BRIP1 and PALB2 in Jewish high cancer risk families publication-title: Fam Cancer – volume: 98 start-page: 638 year: 2002 end-page: 639 ident: bib89 article-title: No mutations in the BACH1 gene in BRCA1 and BRCA2 negative breast-cancer families linked to 17q22 publication-title: Int J Cancer – volume: 266 start-page: 66 year: 1994 end-page: 71 ident: bib11 article-title: A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1 publication-title: Science – volume: 122 start-page: 802 year: 2008 end-page: 806 ident: bib94 article-title: Nijmegen breakage syndrome mutations and risk of breast cancer publication-title: Int J Cancer – volume: 43 start-page: 1066 year: 2011 end-page: 1073 ident: bib38 article-title: Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease publication-title: Nat Genet – volume: 25 year: 2006 ident: bib73 article-title: ATM and breast cancer susceptibility publication-title: Oncogene – volume: 136 start-page: E359 year: 2015 end-page: E386 ident: bib125 article-title: Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 publication-title: Int J Cancer – volume: 114 start-page: 3591 year: 2001 end-page: 3598 ident: bib13 article-title: Functions of BRCA1 and BRCA2 in the biological response to DNA damage publication-title: J Cell Sci – volume: 20 start-page: 3278 year: 2011 end-page: 3288 ident: bib98 article-title: RAD51C is a susceptibility gene for ovarian cancer publication-title: Hum Mol Genet – volume: 371 start-page: 497 year: 2014 end-page: 506 ident: bib93 article-title: Breast-cancer risk in families with mutations in PALB2 publication-title: N Engl J Med – volume: 70 start-page: 937 year: 1992 end-page: 948 ident: bib54 article-title: Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles publication-title: Cell – volume: 39 start-page: 366 year: 2003 end-page: 371 ident: bib87 article-title: No evidence of involvement of germline BACH1 mutations in Finnish breast and ovarian cancer families publication-title: Eur J Cancer – start-page: 1360 year: 2012 ident: bib109 article-title: Mice lacking a Myc enhancer that includes human SNP rs6983267 are resistant to intestinal tumors publication-title: Science – volume: 486 start-page: 400 year: 2012 end-page: 404 ident: bib120 article-title: The landscape of cancer genes and mutational processes in breast cancer publication-title: Nature – volume: 16 start-page: 830 year: 2014 ident: bib19 article-title: Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2,000 patients publication-title: Genet Med – volume: 38 start-page: 873 year: 2006 end-page: 875 ident: bib27 article-title: ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles publication-title: Nat Genet – volume: 27 start-page: 1593 year: 2006 end-page: 1599 ident: bib70 article-title: RAD50 and NBS1 are breast cancer susceptibility genes associated with genomic instability publication-title: Carcinogenesis – volume: 90 start-page: 7 year: 2012 end-page: 24 ident: bib31 article-title: Five years of GWAS discovery publication-title: Am J Hum Genet – volume: 114 start-page: 667 year: 1998 end-page: 668 ident: bib47 article-title: A serine/threonine kinase gene defective in Peutz-Jeghers syndrome publication-title: Nature – volume: 502 start-page: 69 year: 2002 end-page: 80 ident: bib56 article-title: Radiation-induced genetic instability in vivo depends on p53 status publication-title: Mutat Res – volume: 22 start-page: 719 year: 2006 end-page: 729 ident: bib92 article-title: Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2 publication-title: Mol Cell – volume: 470 start-page: 198 year: 2011 end-page: 203 ident: bib40 article-title: A decade's perspective on DNA sequencing technology publication-title: Nature – volume: 21 start-page: R10 year: 2012 end-page: R17 ident: bib121 article-title: Inferring causality and functional significance of human coding DNA variants publication-title: Hum Mol Genet – volume: 40 start-page: 17 year: 2008 ident: bib17 article-title: The emerging landscape of breast cancer susceptibility publication-title: Nat Genet – volume: 83 start-page: 7353 year: 1986 end-page: 7357 ident: bib22 article-title: Strategies for studying heterogeneous genetic traits in humans by using a linkage map of restriction fragment length polymorphisms publication-title: Proc Natl Acad Sci USA – volume: 39 start-page: 865 year: 2007 end-page: 869 ident: bib107 article-title: Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer publication-title: Nat Genet – volume: 30 start-page: 1411 year: 2010 end-page: 1420 ident: bib110 article-title: Upregulation of c-MYC in cis through a large chromatin loop linked to a cancer risk-associated single-nucleotide polymorphism in colorectal cancer cells publication-title: Mol Cell Biol – volume: 22 start-page: 1305 year: 2014 ident: bib18 article-title: Next-generation sequencing for the diagnosis of hereditary breast and ovarian cancer using genomic capture targeting multiple candidate genes publication-title: Eur J Hum Genet – volume: 7 start-page: R1005 year: 2005 end-page: R1016 ident: bib82 article-title: Mutation analysis of FANCD2, BRIP1/BACH1, LMO4 and SFN in familial breast cancer publication-title: Breast Cancer Res Treat – volume: 63 start-page: 11 year: 2013 end-page: 30 ident: bib2 article-title: Cancer statistics publication-title: Cancer J Clin – volume: 12 start-page: 477 year: 2011 end-page: 488 ident: bib102 article-title: Genetic variants associated with breast-cancer risk: comprehensive research synopsis, meta-analysis, and epidemiological evidence publication-title: Lancet Oncol – volume: 39 start-page: 870 year: 2007 end-page: 874 ident: bib106 article-title: A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer publication-title: Nat Genet – volume: 8 start-page: 155 year: 2008 ident: bib14 article-title: Penetrance estimates for BRCA1 and BRCA2 based on genetic testing in a clinical cancer genetics service setting: risks of breast/ovarian cancer quoted should reflect the cancer burden in the family publication-title: BMC Cancer – volume: 71 start-page: 747 year: 1969 end-page: 752 ident: bib53 article-title: Soft-tissue sarcomas, breast cancer, and other NeoplasmsA familial syndrome? publication-title: Ann Intern Med – volume: 41 start-page: 885 year: 2009 end-page: 890 ident: bib39 article-title: The common colorectal cancer predisposition SNP rs6983267 at chromosome 8q24 confers potential to enhanced Wnt signaling publication-title: Nat Genet – volume: 115 start-page: 51 year: 2009 end-page: 55 ident: bib83 article-title: Mutation analysis of BRIP1/BACH1 in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives publication-title: Breast Cancer Res Treat – volume: 485 start-page: S50 year: 2012 end-page: S51 ident: bib3 article-title: The hard facts publication-title: Nature – volume: 273 start-page: 1516 year: 1996 end-page: 1517 ident: bib101 article-title: The future of genetic studies of complex human diseases publication-title: Science – volume: 47 start-page: 771 year: 2010 ident: bib58 article-title: A novel HER2-positive breast cancer phenotype arising from germline TP53 mutations publication-title: J Med Genet – volume: 286 start-page: 2528 year: 1999 end-page: 2531 ident: bib79 article-title: Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome publication-title: Science – volume: 141 start-page: 210 year: 2010 end-page: 217 ident: bib33 article-title: Genetic heterogeneity in human disease publication-title: Cell – volume: 14 start-page: 295 year: 2013 end-page: 300 ident: bib123 article-title: Disease-targeted sequencing: a cornerstone in the clinic publication-title: Nat Rev Genet – volume: 267 start-page: 386 year: 1995 end-page: 389 ident: bib59 article-title: Solution structure of the epithelial cadherin domain responsible for selective cell adhesion publication-title: Science – volume: 71 start-page: 432 year: 2002 end-page: 438 ident: bib28 article-title: A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer publication-title: Am J Hum Genet – volume: 20 start-page: 201 year: 2010 end-page: 209 ident: bib108 article-title: Genome-wide association studies in common cancers–what have we learnt? publication-title: Curr Opin Genet Dev – volume: 42 start-page: 30 year: 2010 end-page: 35 ident: bib45 article-title: Exome sequencing identifies the cause of a mendelian disorder publication-title: Nat Genet – volume: 9 start-page: 321 year: 2008 end-page: 345 ident: bib52 article-title: Genetic predisposition to breast cancer: past, present, and future publication-title: Annu Rev Genomics Hum Genet – volume: 8 start-page: R12 year: 2006 ident: bib16 article-title: Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource publication-title: Breast Cancer Res – volume: 6 start-page: 19 year: 2006 ident: bib91 article-title: BACH1 Ser919Pro variant and breast cancer risk publication-title: BMC Cancer – volume: 275 start-page: 1943 year: 1997 end-page: 1947 ident: bib63 article-title: PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer publication-title: Science – volume: 39 start-page: 352 year: 2007 end-page: 358 ident: bib104 article-title: A common coding variant in CASP8 is associated with breast cancer risk publication-title: Nat Genet – volume: 32 start-page: 314 year: 1980 end-page: 331 ident: bib21 article-title: Construction of a genetic linkage map in man using restriction fragment length polymorphisms publication-title: Am J Hum Genet – volume: 337 start-page: 1190 year: 2012 end-page: 1195 ident: bib36 article-title: Systematic localization of common disease-associated variation in regulatory DNA publication-title: Science – volume: 493 start-page: 406 year: 2013 end-page: 410 ident: bib46 article-title: Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancer publication-title: Nature – volume: 66 start-page: 494 year: 2000 end-page: 500 ident: bib65 article-title: ATM-heterozygous germline mutations contribute to breast cancer-susceptibility publication-title: Am J Hum Genet – year: 2014 ident: bib114 publication-title: The NCCN clinical practice guidelines in Oncology – volume: 250 start-page: 1233 year: 1990 end-page: 1238 ident: bib55 article-title: Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms publication-title: Science – volume: 47 start-page: 373 year: 2015 end-page: 380 ident: bib103 article-title: Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer publication-title: Nat Genet – volume: 339 start-page: 959 year: 2013 end-page: 961 ident: bib111 article-title: TERT promoter mutations in familial and sporadic melanoma publication-title: Science – volume: 8 start-page: e1002894 year: 2012 ident: bib116 article-title: Exome sequencing identifies rare deleterious mutations in DNA repair genes FANCC and BLM as potential breast cancer susceptibility alleles publication-title: PLoS Genet – volume: 258 start-page: 427 year: 1975 end-page: 429 ident: bib75 article-title: Ataxia telangiectasia: a human mutation with abnormal radiation sensitivity publication-title: Nature – volume: 25 start-page: 5912 year: 2006 end-page: 5919 ident: bib78 article-title: The CHEK2 gene and inherited breast cancer susceptibility publication-title: Oncogene – year: 2008 ident: bib1 article-title: The global burden of disease: 2004 update – volume: 147 start-page: 133 year: 2014 end-page: 143 ident: bib99 article-title: RAD51C germline mutations found in Spanish site-specific breast cancer and breast–ovarian cancer families publication-title: Breast Cancer Res Treat – volume: 4 start-page: 45 year: 2002 end-page: 61 ident: bib35 article-title: A comprehensive review of genetic association studies publication-title: Genet Med – volume: 22 start-page: 121 year: 2003 end-page: 128 ident: bib90 article-title: Mutational analysis of the BRCA1-interacting genes ZNF350/ZBRK1 and BRIP1/BACH1 among BRCA1 and BRCA2-negative probands from breast-ovarian cancer families and among early-onset breast cancer cases and reference individuals publication-title: Hum Mutat – volume: 375 start-page: 2143 year: 2010 end-page: 2151 ident: bib9 article-title: Gene-environment interactions in 7610 women with breast cancer: prospective evidence from the million women Study publication-title: Lancet – volume: 8 start-page: e55681 year: 2013 ident: bib115 article-title: Whole exome sequencing suggests much of non- BRCA1/BRCA2 familial breast cancer is due to moderate and low penetrance susceptibility alleles publication-title: PloS One – volume: 339 start-page: 957 year: 2013 end-page: 959 ident: bib112 article-title: Highly recurrent TERT promoter mutations in human melanoma publication-title: Science – volume: 82 start-page: 105 year: 2012 end-page: 114 ident: bib50 article-title: Familial breast cancer publication-title: Clin Genet – volume: 63 start-page: 11 issue: 1 year: 2013 ident: 10.1016/j.suronc.2015.04.003_bib2 article-title: Cancer statistics publication-title: Cancer J Clin doi: 10.3322/caac.21166 – volume: 266 start-page: 66 issue: 5182 year: 1994 ident: 10.1016/j.suronc.2015.04.003_bib11 article-title: A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1 publication-title: Science doi: 10.1126/science.7545954 – volume: 114 start-page: 667 issue: 7 year: 1998 ident: 10.1016/j.suronc.2015.04.003_bib47 article-title: A serine/threonine kinase gene defective in Peutz-Jeghers syndrome publication-title: Nature – volume: 8 start-page: 155 year: 2008 ident: 10.1016/j.suronc.2015.04.003_bib14 article-title: Penetrance estimates for BRCA1 and BRCA2 based on genetic testing in a clinical cancer genetics service setting: risks of breast/ovarian cancer quoted should reflect the cancer burden in the family publication-title: BMC Cancer doi: 10.1186/1471-2407-8-155 – volume: 97 start-page: 9603 issue: 17 year: 2000 ident: 10.1016/j.suronc.2015.04.003_bib67 article-title: Somatic deletions in hereditary breast cancers implicate 13q21 as a putative novel breast cancer susceptibility locus publication-title: PNAS doi: 10.1073/pnas.97.17.9603 – volume: 8 start-page: e55681 issue: 2 year: 2013 ident: 10.1016/j.suronc.2015.04.003_bib115 article-title: Whole exome sequencing suggests much of non- BRCA1/BRCA2 familial breast cancer is due to moderate and low penetrance susceptibility alleles publication-title: PloS One doi: 10.1371/journal.pone.0055681 – volume: 343 start-page: 78 issue: 2 year: 2000 ident: 10.1016/j.suronc.2015.04.003_bib8 article-title: Environmental and heritable factors in the causation of cancer—analyses of cohorts of twins from Sweden, Denmark, and Finland publication-title: N Engl J Med doi: 10.1056/NEJM200007133430201 – volume: 141 start-page: 210 issue: 2 year: 2010 ident: 10.1016/j.suronc.2015.04.003_bib33 article-title: Genetic heterogeneity in human disease publication-title: Cell doi: 10.1016/j.cell.2010.03.032 – volume: 41 start-page: 882 issue: 8 year: 2009 ident: 10.1016/j.suronc.2015.04.003_bib37 article-title: The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer publication-title: Nature – volume: 14 start-page: 249 year: 1999 ident: 10.1016/j.suronc.2015.04.003_bib60 article-title: E-cadherin germline mutations define an inherited cancer syndrome dominated by diffuse gastric cancer publication-title: Hum Mutat doi: 10.1002/(SICI)1098-1004(1999)14:3<249::AID-HUMU8>3.0.CO;2-9 – volume: 38 start-page: 1239 issue: 11 year: 2006 ident: 10.1016/j.suronc.2015.04.003_bib68 article-title: Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles publication-title: Nat Genet doi: 10.1038/ng1902 – volume: 493 start-page: 406 issue: 7432 year: 2013 ident: 10.1016/j.suronc.2015.04.003_bib46 article-title: Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancer publication-title: Nature doi: 10.1038/nature11725 – volume: 115 start-page: 51 issue: 1 year: 2009 ident: 10.1016/j.suronc.2015.04.003_bib83 article-title: Mutation analysis of BRIP1/BACH1 in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives publication-title: Breast Cancer Res Treat doi: 10.1007/s10549-008-0052-z – volume: 13 start-page: R20 issue: 1 year: 2011 ident: 10.1016/j.suronc.2015.04.003_bib88 article-title: Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals publication-title: Breast Cancer Res Treat doi: 10.1186/bcr2832 – year: 2014 ident: 10.1016/j.suronc.2015.04.003_bib114 – volume: 39 start-page: 165 issue: 2 year: 2007 ident: 10.1016/j.suronc.2015.04.003_bib26 article-title: PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene publication-title: Nat Genet doi: 10.1038/ng1959 – year: 2008 ident: 10.1016/j.suronc.2015.04.003_bib1 – volume: 147 start-page: 133 issue: 1 year: 2014 ident: 10.1016/j.suronc.2015.04.003_bib99 article-title: RAD51C germline mutations found in Spanish site-specific breast cancer and breast–ovarian cancer families publication-title: Breast Cancer Res Treat doi: 10.1007/s10549-014-3078-4 – volume: 39 start-page: 870 issue: 7 year: 2007 ident: 10.1016/j.suronc.2015.04.003_bib106 article-title: A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer publication-title: Nat Genet doi: 10.1038/ng2075 – volume: 6 start-page: 19 year: 2006 ident: 10.1016/j.suronc.2015.04.003_bib91 article-title: BACH1 Ser919Pro variant and breast cancer risk publication-title: BMC Cancer doi: 10.1186/1471-2407-6-19 – volume: 358 start-page: 1389 year: 2001 ident: 10.1016/j.suronc.2015.04.003_bib6 article-title: Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58 209 women with breast cancer and 101 986 women without the disease publication-title: Lancet doi: 10.1016/S0140-6736(01)06524-2 – volume: 83 start-page: 7353 year: 1986 ident: 10.1016/j.suronc.2015.04.003_bib22 article-title: Strategies for studying heterogeneous genetic traits in humans by using a linkage map of restriction fragment length polymorphisms publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.83.19.7353 – volume: 39 start-page: D945 issue: Database issue year: 2011 ident: 10.1016/j.suronc.2015.04.003_bib51 article-title: COSMIC: mining complete cancer genomes in the catalogue of somatic mutations in cancer publication-title: Nucleic Acids Res doi: 10.1093/nar/gkq929 – volume: 446 start-page: 316 issue: 7133 year: 2007 ident: 10.1016/j.suronc.2015.04.003_bib71 article-title: A recurrent mutation in PALB2 in Finnish cancer families publication-title: Nature doi: 10.1038/nature05609 – volume: 74 start-page: 1175 issue: 6 year: 2004 ident: 10.1016/j.suronc.2015.04.003_bib72 article-title: CHEK2*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies publication-title: Am J Hum Genet doi: 10.1086/421251 – volume: 371 start-page: 497 year: 2014 ident: 10.1016/j.suronc.2015.04.003_bib93 article-title: Breast-cancer risk in families with mutations in PALB2 publication-title: N Engl J Med doi: 10.1056/NEJMoa1400382 – volume: 39 start-page: 865 issue: 7 year: 2007 ident: 10.1016/j.suronc.2015.04.003_bib107 article-title: Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer publication-title: Nat Genet doi: 10.1038/ng2064 – volume: 134 start-page: 429 issue: 1 year: 2012 ident: 10.1016/j.suronc.2015.04.003_bib43 article-title: Predisposition gene identification in common cancers by exome sequencing: insights from familial breast cancer publication-title: Breast Cancer Res Treat doi: 10.1007/s10549-012-2057-x – volume: 275 start-page: 1943 year: 1997 ident: 10.1016/j.suronc.2015.04.003_bib63 article-title: PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer publication-title: Science doi: 10.1126/science.275.5308.1943 – volume: 82 start-page: 105 issue: 2 year: 2012 ident: 10.1016/j.suronc.2015.04.003_bib50 article-title: Familial breast cancer publication-title: Clin Genet doi: 10.1111/j.1399-0004.2012.01859.x – volume: 258 start-page: 427 year: 1975 ident: 10.1016/j.suronc.2015.04.003_bib75 article-title: Ataxia telangiectasia: a human mutation with abnormal radiation sensitivity publication-title: Nature doi: 10.1038/258427a0 – volume: 122 start-page: 802 issue: 4 year: 2008 ident: 10.1016/j.suronc.2015.04.003_bib94 article-title: Nijmegen breakage syndrome mutations and risk of breast cancer publication-title: Int J Cancer doi: 10.1002/ijc.23168 – volume: 14 start-page: 6107 issue: 24 year: 1995 ident: 10.1016/j.suronc.2015.04.003_bib49 article-title: E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers publication-title: EMBO J doi: 10.1002/j.1460-2075.1995.tb00301.x – volume: 502 start-page: 69 year: 2002 ident: 10.1016/j.suronc.2015.04.003_bib56 article-title: Radiation-induced genetic instability in vivo depends on p53 status publication-title: Mutat Res doi: 10.1016/S0027-5107(02)00029-5 – volume: 8 start-page: R12 issue: 1 year: 2006 ident: 10.1016/j.suronc.2015.04.003_bib16 article-title: Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource publication-title: Breast Cancer Res doi: 10.1186/bcr1377 – volume: 43 start-page: 1066 issue: 11 year: 2011 ident: 10.1016/j.suronc.2015.04.003_bib38 article-title: Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease publication-title: Nat Genet doi: 10.1038/ng.952 – volume: 470 start-page: 198 issue: 7333 year: 2011 ident: 10.1016/j.suronc.2015.04.003_bib40 article-title: A decade's perspective on DNA sequencing technology publication-title: Nature doi: 10.1038/nature09796 – volume: 115 start-page: 2222 issue: 10 year: 2009 ident: 10.1016/j.suronc.2015.04.003_bib15 article-title: BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer publication-title: Cancer doi: 10.1002/cncr.24200 – volume: 250 start-page: 1233 issue: 4985 year: 1990 ident: 10.1016/j.suronc.2015.04.003_bib55 article-title: Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms publication-title: Science doi: 10.1126/science.1978757 – volume: 375 start-page: 2143 issue: 9732 year: 2010 ident: 10.1016/j.suronc.2015.04.003_bib9 article-title: Gene-environment interactions in 7610 women with breast cancer: prospective evidence from the million women Study publication-title: Lancet doi: 10.1016/S0140-6736(10)60636-8 – volume: 40 start-page: 17 year: 2008 ident: 10.1016/j.suronc.2015.04.003_bib17 article-title: The emerging landscape of breast cancer susceptibility publication-title: Nat Genet doi: 10.1038/ng.2007.53 – volume: 265 start-page: 15 year: 1994 ident: 10.1016/j.suronc.2015.04.003_bib12 article-title: Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13 publication-title: Science doi: 10.1126/science.8091231 – volume: 337 start-page: 1190 issue: 6099 year: 2012 ident: 10.1016/j.suronc.2015.04.003_bib36 article-title: Systematic localization of common disease-associated variation in regulatory DNA publication-title: Science doi: 10.1126/science.1222794 – volume: 126 start-page: 1788 year: 2004 ident: 10.1016/j.suronc.2015.04.003_bib64 article-title: Relative frequency and morphology of cancers in STK11 mutation carriers publication-title: Gastroenterology doi: 10.1053/j.gastro.2004.03.014 – volume: 102 start-page: 475 year: 2010 ident: 10.1016/j.suronc.2015.04.003_bib76 article-title: Radiation exposure, the ATM gene, and contralateral breast cancer in the women's environmental cancer and radiation epidemiology study publication-title: J Natl Cancer Inst doi: 10.1093/jnci/djq055 – volume: 107 start-page: 12629 year: 2010 ident: 10.1016/j.suronc.2015.04.003_bib20 article-title: Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencing publication-title: Proc Natl Acad Sci doi: 10.1073/pnas.1007983107 – volume: 70 start-page: 937 issue: 6 year: 1992 ident: 10.1016/j.suronc.2015.04.003_bib54 article-title: Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles publication-title: Cell doi: 10.1016/0092-8674(92)90244-7 – volume: 105 start-page: 149 year: 2001 ident: 10.1016/j.suronc.2015.04.003_bib81 article-title: BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function publication-title: Cell doi: 10.1016/S0092-8674(01)00304-X – volume: 9 start-page: 321 year: 2008 ident: 10.1016/j.suronc.2015.04.003_bib52 article-title: Genetic predisposition to breast cancer: past, present, and future publication-title: Annu Rev Genomics Hum Genet doi: 10.1146/annurev.genom.9.081307.164339 – volume: 273 start-page: 1516 issue: 5281 year: 1996 ident: 10.1016/j.suronc.2015.04.003_bib101 article-title: The future of genetic studies of complex human diseases publication-title: Science doi: 10.1126/science.273.5281.1516 – volume: 303 start-page: 631 issue: 7 year: 2010 ident: 10.1016/j.suronc.2015.04.003_bib34 article-title: Association between a literature-based genetic risk score and cardiovascular events in women publication-title: JAMA doi: 10.1001/jama.2010.119 – volume: 267 start-page: 386 year: 1995 ident: 10.1016/j.suronc.2015.04.003_bib59 article-title: Solution structure of the epithelial cadherin domain responsible for selective cell adhesion publication-title: Science doi: 10.1126/science.7824937 – volume: 13 start-page: 36 issue: 1 year: 2012 ident: 10.1016/j.suronc.2015.04.003_bib42 article-title: Repetitive DNA and next-generation sequencing: computational challenges and solutions publication-title: Nat Rev Genet doi: 10.1038/nrg3117 – volume: 316 start-page: 1289 year: 1987 ident: 10.1016/j.suronc.2015.04.003_bib66 article-title: Breast and other cancers in families with ataxia-telangiectasia publication-title: N Engl J Med doi: 10.1056/NEJM198705213162101 – volume: 90 start-page: 7 issue: 1 year: 2012 ident: 10.1016/j.suronc.2015.04.003_bib31 article-title: Five years of GWAS discovery publication-title: Am J Hum Genet doi: 10.1016/j.ajhg.2011.11.029 – volume: 53 start-page: 579 issue: 7 year: 2008 ident: 10.1016/j.suronc.2015.04.003_bib86 article-title: Mutational analysis of the breast cancer susceptibility gene BRIP1/BACH1/FANCJ in high-risk non-BRCA1/BRCA2 breast cancer families publication-title: J Hum Genet doi: 10.1007/s10038-008-0285-z – volume: 136 start-page: E359 issue: 5 year: 2015 ident: 10.1016/j.suronc.2015.04.003_bib125 article-title: Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 publication-title: Int J Cancer doi: 10.1002/ijc.29210 – volume: 486 start-page: 400 issue: 7403 year: 2012 ident: 10.1016/j.suronc.2015.04.003_bib120 article-title: The landscape of cancer genes and mutational processes in breast cancer publication-title: Nature doi: 10.1038/nature11017 – volume: 20 start-page: 201 issue: 3 year: 2010 ident: 10.1016/j.suronc.2015.04.003_bib108 article-title: Genome-wide association studies in common cancers–what have we learnt? publication-title: Curr Opin Genet Dev doi: 10.1016/j.gde.2010.03.012 – volume: 40 start-page: 1 year: 2003 ident: 10.1016/j.suronc.2015.04.003_bib69 article-title: Mutation screening of Mre11 complex genes: indication of RAD50 involvement in breast and ovarian cancer susceptibility publication-title: J Med Genet doi: 10.1136/jmg.40.12.e131 – volume: 74 start-page: 5463 year: 1977 ident: 10.1016/j.suronc.2015.04.003_bib41 article-title: DNA sequencing with chain-terminating inhibitors publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.74.12.5463 – volume: 145 start-page: 775 issue: 3 year: 2014 ident: 10.1016/j.suronc.2015.04.003_bib100 article-title: Deleterious RAD51C germline mutations rarely predispose to breast and ovarian cancer in Pakistan publication-title: Breast Cancer Res Treat doi: 10.1007/s10549-014-2972-0 – volume: 432 start-page: 316 year: 2004 ident: 10.1016/j.suronc.2015.04.003_bib77 article-title: Cell-cycle checkpoints and cancer publication-title: Nature doi: 10.1038/nature03097 – volume: 7 start-page: 83 year: 2007 ident: 10.1016/j.suronc.2015.04.003_bib85 article-title: BRIP1 (BACH1) variants and familial breast cancer risk: a case-control study publication-title: BMC Cancer doi: 10.1186/1471-2407-7-83 – volume: 14 start-page: 295 issue: 4 year: 2013 ident: 10.1016/j.suronc.2015.04.003_bib123 article-title: Disease-targeted sequencing: a cornerstone in the clinic publication-title: Nat Rev Genet doi: 10.1038/nrg3463 – volume: 152 start-page: 950 issue: 10 year: 2000 ident: 10.1016/j.suronc.2015.04.003_bib5 article-title: Cumulative risk of breast cancer to age 70 years according to risk factor status: data from the Nurses' health Study publication-title: Am J Epidemiol doi: 10.1093/aje/152.10.950 – volume: 7 start-page: 277 issue: 3 year: 1955 ident: 10.1016/j.suronc.2015.04.003_bib23 article-title: Sequential tests for the detection of linkage publication-title: Am J Hum Genet – volume: 322 start-page: 32 year: 1986 ident: 10.1016/j.suronc.2015.04.003_bib25 article-title: Cloning the gene for the inherited disorder chronic granulomatous disease on the basis of its chromosomal location publication-title: Nature doi: 10.1038/322032a0 – volume: 461 start-page: 747 issue: 7265 year: 2009 ident: 10.1016/j.suronc.2015.04.003_bib32 article-title: Finding the missing heritability of complex diseases publication-title: Nature doi: 10.1038/nature08494 – volume: 8 start-page: e55734 issue: 1 year: 2013 ident: 10.1016/j.suronc.2015.04.003_bib118 article-title: Exome sequencing of germline DNA from non-BRCA1/2 familial breast cancer cases selected on the basis of aCGH tumor profiling publication-title: PloS One doi: 10.1371/journal.pone.0055734 – volume: 9 start-page: 213 issue: 5 year: 2007 ident: 10.1016/j.suronc.2015.04.003_bib7 article-title: Breast cancer risk-assessment models publication-title: Breast Cancer Res doi: 10.1186/bcr1750 – volume: 38 start-page: 873 issue: 8 year: 2006 ident: 10.1016/j.suronc.2015.04.003_bib27 article-title: ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles publication-title: Nat Genet doi: 10.1038/ng1837 – volume: 41 start-page: 885 issue: 8 year: 2009 ident: 10.1016/j.suronc.2015.04.003_bib39 article-title: The common colorectal cancer predisposition SNP rs6983267 at chromosome 8q24 confers potential to enhanced Wnt signaling publication-title: Nat Genet doi: 10.1038/ng.406 – volume: 114 start-page: 3591 year: 2001 ident: 10.1016/j.suronc.2015.04.003_bib13 article-title: Functions of BRCA1 and BRCA2 in the biological response to DNA damage publication-title: J Cell Sci doi: 10.1242/jcs.114.20.3591 – volume: 4 start-page: 45 issue: 2 year: 2002 ident: 10.1016/j.suronc.2015.04.003_bib35 article-title: A comprehensive review of genetic association studies publication-title: Genet Med doi: 10.1097/00125817-200203000-00002 – volume: 27 start-page: 1593 year: 2006 ident: 10.1016/j.suronc.2015.04.003_bib70 article-title: RAD50 and NBS1 are breast cancer susceptibility genes associated with genomic instability publication-title: Carcinogenesis doi: 10.1093/carcin/bgi360 – volume: 6 start-page: 48 year: 2006 ident: 10.1016/j.suronc.2015.04.003_bib62 article-title: CDH1 promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer publication-title: BMC Cancer doi: 10.1186/1471-2407-6-48 – volume: 8 start-page: e1002894 issue: 9 year: 2012 ident: 10.1016/j.suronc.2015.04.003_bib116 article-title: Exome sequencing identifies rare deleterious mutations in DNA repair genes FANCC and BLM as potential breast cancer susceptibility alleles publication-title: PLoS Genet doi: 10.1371/journal.pgen.1002894 – volume: 130 start-page: 1043 issue: 3 year: 2011 ident: 10.1016/j.suronc.2015.04.003_bib117 article-title: FAN1 variants identified in multiple-case early-onset breast cancer families via exome sequencing: no evidence for association with risk for breast cancer publication-title: Breast Cancer Res Treat doi: 10.1007/s10549-011-1704-y – volume: 16 start-page: 830 year: 2014 ident: 10.1016/j.suronc.2015.04.003_bib19 article-title: Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2,000 patients publication-title: Genet Med doi: 10.1038/gim.2014.40 – volume: 47 start-page: 771 issue: 11 year: 2010 ident: 10.1016/j.suronc.2015.04.003_bib58 article-title: A novel HER2-positive breast cancer phenotype arising from germline TP53 mutations publication-title: J Med Genet doi: 10.1136/jmg.2010.078113 – volume: 20 start-page: 3278 year: 2011 ident: 10.1016/j.suronc.2015.04.003_bib98 article-title: RAD51C is a susceptibility gene for ovarian cancer publication-title: Hum Mol Genet doi: 10.1093/hmg/ddr229 – volume: 115 start-page: 85 year: 2001 ident: 10.1016/j.suronc.2015.04.003_bib61 article-title: Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications publication-title: Am J Clin Pathology doi: 10.1309/FDHX-L92R-BATQ-2GE0 – volume: 11 start-page: 483 issue: 3 year: 2012 ident: 10.1016/j.suronc.2015.04.003_bib84 article-title: Germline mutations in BRIP1 and PALB2 in Jewish high cancer risk families publication-title: Fam Cancer doi: 10.1007/s10689-012-9540-8 – volume: 250 start-page: 17 year: 1990 ident: 10.1016/j.suronc.2015.04.003_bib10 article-title: Linkage of early-onset familial breast cancer to chromosome 17q21 publication-title: Science doi: 10.1126/science.2270482 – volume: 39 start-page: 352 issue: 3 year: 2007 ident: 10.1016/j.suronc.2015.04.003_bib104 article-title: A common coding variant in CASP8 is associated with breast cancer risk publication-title: Nat Genet doi: 10.1038/ng1981 – volume: 32 start-page: 95 year: 2013 ident: 10.1016/j.suronc.2015.04.003_bib74 article-title: ATM-depletion in breast cancer cells confers sensitivity to PARP inhibition publication-title: J Exp Clin Cancer Res doi: 10.1186/1756-9966-32-95 – volume: 22 start-page: 121 issue: 2 year: 2003 ident: 10.1016/j.suronc.2015.04.003_bib90 article-title: Mutational analysis of the BRCA1-interacting genes ZNF350/ZBRK1 and BRIP1/BACH1 among BRCA1 and BRCA2-negative probands from breast-ovarian cancer families and among early-onset breast cancer cases and reference individuals publication-title: Hum Mutat doi: 10.1002/humu.10238 – volume: 71 start-page: 747 year: 1969 ident: 10.1016/j.suronc.2015.04.003_bib53 article-title: Soft-tissue sarcomas, breast cancer, and other NeoplasmsA familial syndrome? publication-title: Ann Intern Med doi: 10.7326/0003-4819-71-4-747 – volume: 16 start-page: 830 year: 2014 ident: 10.1016/j.suronc.2015.04.003_bib124 article-title: Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2,000 patients publication-title: Genet Med doi: 10.1038/gim.2014.40 – volume: 25 start-page: 347 issue: 3 year: 2000 ident: 10.1016/j.suronc.2015.04.003_bib96 article-title: Cell-cycle-regulated association of RAD50/MRE11/NBS1 with TRF2 and human telomeres publication-title: Nat Genet doi: 10.1038/77139 – volume: 42 start-page: 30 issue: 1 year: 2010 ident: 10.1016/j.suronc.2015.04.003_bib45 article-title: Exome sequencing identifies the cause of a mendelian disorder publication-title: Nat Genet doi: 10.1038/ng.499 – volume: 286 start-page: 2528 year: 1999 ident: 10.1016/j.suronc.2015.04.003_bib79 article-title: Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome publication-title: Science doi: 10.1126/science.286.5449.2528 – volume: 66 start-page: 494 year: 2000 ident: 10.1016/j.suronc.2015.04.003_bib65 article-title: ATM-heterozygous germline mutations contribute to breast cancer-susceptibility publication-title: Am J Hum Genet doi: 10.1086/302746 – volume: 102 start-page: 680 issue: 10 year: 2010 ident: 10.1016/j.suronc.2015.04.003_bib4 article-title: Assessing women at high risk of breast cancer: a review of risk assessment models publication-title: J Natl Cancer Inst doi: 10.1093/jnci/djq088 – volume: 22 start-page: 1305 year: 2014 ident: 10.1016/j.suronc.2015.04.003_bib18 article-title: Next-generation sequencing for the diagnosis of hereditary breast and ovarian cancer using genomic capture targeting multiple candidate genes publication-title: Eur J Hum Genet doi: 10.1038/ejhg.2014.16 – volume: 118 start-page: 908 year: 2012 ident: 10.1016/j.suronc.2015.04.003_bib57 article-title: Early onset HER2-positive breast cancer is associated with germline TP53 mutations publication-title: Cancer doi: 10.1002/cncr.26377 – volume: 25 issue: 43 year: 2006 ident: 10.1016/j.suronc.2015.04.003_bib73 article-title: ATM and breast cancer susceptibility publication-title: Oncogene doi: 10.1038/sj.onc.1209873 – volume: 47 start-page: 373 issue: 4 year: 2015 ident: 10.1016/j.suronc.2015.04.003_bib103 article-title: Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer publication-title: Nat Genet doi: 10.1038/ng.3242 – volume: 42 start-page: 410 issue: 5 year: 2010 ident: 10.1016/j.suronc.2015.04.003_bib97 article-title: Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene publication-title: Nat Genet doi: 10.1038/ng.569 – volume: 73 start-page: 7162 issue: 24 year: 2013 ident: 10.1016/j.suronc.2015.04.003_bib113 article-title: TERT promoter mutations occur early in urothelial neoplasia and are biomarkers of early disease and disease recurrence in urine publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-13-2498 – volume: 7 start-page: R1005 issue: 6 year: 2005 ident: 10.1016/j.suronc.2015.04.003_bib82 article-title: Mutation analysis of FANCD2, BRIP1/BACH1, LMO4 and SFN in familial breast cancer publication-title: Breast Cancer Res Treat doi: 10.1186/bcr1336 – volume: 32 start-page: 314 year: 1980 ident: 10.1016/j.suronc.2015.04.003_bib21 article-title: Construction of a genetic linkage map in man using restriction fragment length polymorphisms publication-title: Am J Hum Genet – volume: 42 start-page: 790 issue: 9 year: 2010 ident: 10.1016/j.suronc.2015.04.003_bib44 article-title: Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome publication-title: Nat Genet doi: 10.1038/ng.646 – volume: 33 start-page: 177 issue: 2 year: 2003 ident: 10.1016/j.suronc.2015.04.003_bib30 article-title: Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease publication-title: Nat Genet doi: 10.1038/ng1071 – volume: 31 start-page: 55 year: 2008 ident: 10.1016/j.suronc.2015.04.003_bib80 article-title: Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations publication-title: Nat Genet doi: 10.1038/ng879 – volume: 447 start-page: 1087 issue: 7148 year: 2007 ident: 10.1016/j.suronc.2015.04.003_bib105 article-title: Genome-wide association study identifies novel breast cancer susceptibility loci publication-title: Nature doi: 10.1038/nature05887 – volume: 25 start-page: 5912 issue: 43 year: 2006 ident: 10.1016/j.suronc.2015.04.003_bib78 article-title: The CHEK2 gene and inherited breast cancer susceptibility publication-title: Oncogene doi: 10.1038/sj.onc.1209877 – volume: 499 start-page: 214 issue: 7457 year: 2013 ident: 10.1016/j.suronc.2015.04.003_bib119 article-title: Mutational heterogeneity in cancer and the search for new cancer-associated genes publication-title: Nature doi: 10.1038/nature12213 – volume: 3 start-page: 845 issue: 8–9 year: 2004 ident: 10.1016/j.suronc.2015.04.003_bib95 article-title: The Mre11 complex and the metabolism of chromosome breaks: the importance of communicating and holding things together publication-title: DNA Repair doi: 10.1016/j.dnarep.2004.03.014 – volume: 13 start-page: 114 year: 1996 ident: 10.1016/j.suronc.2015.04.003_bib48 article-title: Localization of the gene for Cowden disease to chromosome 10q22-23 publication-title: Nat Genet doi: 10.1038/ng0596-114 – volume: 339 start-page: 959 issue: 6122 year: 2013 ident: 10.1016/j.suronc.2015.04.003_bib111 article-title: TERT promoter mutations in familial and sporadic melanoma publication-title: Science doi: 10.1126/science.1230062 – volume: 485 start-page: S50 issue: 7400 year: 2012 ident: 10.1016/j.suronc.2015.04.003_bib3 article-title: The hard facts publication-title: Nature doi: 10.1038/485S50a – year: 1999 ident: 10.1016/j.suronc.2015.04.003_bib29 – volume: 12 start-page: 477 issue: 5 year: 2011 ident: 10.1016/j.suronc.2015.04.003_bib102 article-title: Genetic variants associated with breast-cancer risk: comprehensive research synopsis, meta-analysis, and epidemiological evidence publication-title: Lancet Oncol doi: 10.1016/S1470-2045(11)70076-6 – volume: 93 start-page: 3471 issue: 8 year: 1996 ident: 10.1016/j.suronc.2015.04.003_bib24 article-title: Logarithm of odds (lods) for linkage in complex inheritance publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.93.8.3471 – volume: 23 start-page: 727 issue: 4 year: 2013 ident: 10.1016/j.suronc.2015.04.003_bib122 article-title: A large-scale zebrafish gene knockout resource for the genome-wide study of gene function publication-title: Genome Res doi: 10.1101/gr.151464.112 – volume: 30 start-page: 1411 issue: 6 year: 2010 ident: 10.1016/j.suronc.2015.04.003_bib110 article-title: Upregulation of c-MYC in cis through a large chromatin loop linked to a cancer risk-associated single-nucleotide polymorphism in colorectal cancer cells publication-title: Mol Cell Biol doi: 10.1128/MCB.01384-09 – volume: 21 start-page: R10 issue: R1 year: 2012 ident: 10.1016/j.suronc.2015.04.003_bib121 article-title: Inferring causality and functional significance of human coding DNA variants publication-title: Hum Mol Genet doi: 10.1093/hmg/dds385 – volume: 339 start-page: 957 issue: 6122 year: 2013 ident: 10.1016/j.suronc.2015.04.003_bib112 article-title: Highly recurrent TERT promoter mutations in human melanoma publication-title: Science doi: 10.1126/science.1229259 – volume: 98 start-page: 638 issue: 4 year: 2002 ident: 10.1016/j.suronc.2015.04.003_bib89 article-title: No mutations in the BACH1 gene in BRCA1 and BRCA2 negative breast-cancer families linked to 17q22 publication-title: Int J Cancer doi: 10.1002/ijc.10214 – volume: 22 start-page: 719 year: 2006 ident: 10.1016/j.suronc.2015.04.003_bib92 article-title: Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2 publication-title: Mol Cell doi: 10.1016/j.molcel.2006.05.022 – start-page: 1360 year: 2012 ident: 10.1016/j.suronc.2015.04.003_bib109 article-title: Mice lacking a Myc enhancer that includes human SNP rs6983267 are resistant to intestinal tumors publication-title: Science doi: 10.1126/science.1228606 – volume: 39 start-page: 366 issue: 3 year: 2003 ident: 10.1016/j.suronc.2015.04.003_bib87 article-title: No evidence of involvement of germline BACH1 mutations in Finnish breast and ovarian cancer families publication-title: Eur J Cancer doi: 10.1016/S0959-8049(02)00498-7 – volume: 71 start-page: 432 year: 2002 ident: 10.1016/j.suronc.2015.04.003_bib28 article-title: A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer publication-title: Am J Hum Genet doi: 10.1086/341943 |
| SSID | ssj0006721 |
| Score | 2.2035332 |
| SecondaryResourceType | review_article |
| Snippet | Breast cancer is the leading cause of cancer deaths in females worldwide occurring in both hereditary and sporadic forms. Women with inherited pathogenic... Abstract Breast cancer is the leading cause of cancer deaths in females worldwide occurring in both hereditary and sporadic forms. Women with inherited... |
| SourceID | proquest pubmed crossref elsevier |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 100 |
| SubjectTerms | BRCA1 BRCA2 Breast cancer Breast neoplasm Breast Neoplasms - genetics Cadherins - genetics Chromosomes Female Gene loci Genes, BRCA1 Genes, BRCA2 Genes, Neoplasm - genetics Genetic Linkage Genetic predisposition to disease Genetic Predisposition to Disease - genetics Genetics Genome-Wide Association Study - methods Hematology, Oncology and Palliative Medicine Humans Membrane Proteins - genetics Mutation Mutation - genetics PTEN Phosphohydrolase - genetics Sequence analysis Sequence Analysis, DNA Studies Surgery Womens health |
| Title | Gene analysis techniques and susceptibility gene discovery in non-BRCA1/BRCA2 familial breast cancer |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0960740415000250 https://www.clinicalkey.es/playcontent/1-s2.0-S0960740415000250 https://dx.doi.org/10.1016/j.suronc.2015.04.003 https://www.ncbi.nlm.nih.gov/pubmed/25936246 https://www.proquest.com/docview/1685001146 https://www.proquest.com/docview/1702088490 |
| Volume | 24 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1RT9swELYQkyZepo0N1gGVJ_HqtXEc23nsKlDZBA9jSLxZduJMnVBaNe0DL_wWfgu_bHeO025iiGkvkZKcY-tyPp-T774j5JhzD26fwxuospQJ2Lsxp61lic-QuXJY8gI_6J9fyMmV-HKdXW-RcZcLg7DK6Ptbnx68dbwyiNoczKfTwSUG30pgivkwrOSYwS4UWvmnuw3MQ6qQe4XCDKW79LmA8WpWi1mNRIZJFghPu9JZj5enp8LPsAydviavYvxIR-0Q35AtX--Sl-fxD_lb4pFHmtpINULXFK0NXCtps2oCjCUgYm_pD5TFvFzEcd7Saf1wX89q9vnbeJQM8Mhp-AACNkodoteXtEArWbwjV6cn38cTFkspsELkesmSKqmqyiOoSWXOYXKgLNMiL63VheWpzWHnBaGrclpZLZ3MK-SVcaVzORx4uke2YQD-PaGJhTmeiUqXSS40PDN3VerB5UvLdVmqHkk7DZoi8oxjuYsb0wHKfppW7wb1boYC-Ul7hK1bzVuejWfks-7lmC6HFLyegYXgmXbqb-18E6duYxLTcDM0j8zr95Z_WOg_9HnYWY_ZdCN1FjKZZY98XN-GuY0_bGztZyuQUVhCVYscOt9vrW6tHI6lGLmQH_57WAdkB89a3Nsh2V4uVv4IIqyl64cp1CcvRmdfJxe_AKWiJXs |
| linkProvider | Elsevier |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VIgEXBOW1UIorcTW7cRzHOZYV1faxPfQh9WbZiYMWoWy12T30wm_ht_DLmHGcLaigIi45JOPYmsyMJ8k33wC8F8Jj2Bf4BOos5RLf3bjT1vLEZ8RcOapESR_0pydqciEPL7PLDRj3tTAEq4yxv4vpIVrHM8OozeHVbDY8o-Q7l1RiPgo7-T24L9F9qY3Bh283OA-Vh-IrkuYk3tfPBZBXu1rMG2IyTLLAeNr3zrq9P_0t_wz70P4TeBwTSLbXrfEpbPhmCx5M4y_yZ-CJSJrZyDXC1hytLZ6rWLtqA44lQGKv2WeSpcJcAnJes1nz43szb_jH0_FeMqSjYOELCBopcwRfX7KSzGTxHC72P52PJzz2UuClLPSSJ3VS17UnVFOeOUfVgapKy6KyVpdWpLbAVy_MXXOnc6uVU0VNxDKucq7Ag0hfwCYuwL8Cllh08kzWukoKqfGehatTjzFfWaGrKh9A2mvQlJFonPpdfDU9ouyL6fRuSO9mJImgdAB8PeqqI9q4Qz7rH47pi0gx7BncCe4Yl_9pnG-j77YmMa0wI3PLvn4d-ZuJ_sOc2731mJtplM5CKbMawO76Mjo3_bGxjZ-vUCanHqpaFjj5y87q1soR1ItRSPX6v5f1Dh5OzqfH5vjg5OgNPKIrHQhuGzaXi5V_i-nW0u0Ed_oJG2UnCQ |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Gene+analysis+techniques+and+susceptibility+gene+discovery+in%C2%A0non-BRCA1%2FBRCA2+familial+breast+cancer&rft.jtitle=Surgical+oncology&rft.au=Aloraifi%2C+Fatima&rft.au=Boland%2C+Michael+R&rft.au=Green%2C+Andrew+J&rft.au=Geraghty%2C+James+G&rft.date=2015-06-01&rft.issn=0960-7404&rft.volume=24&rft.issue=2&rft.spage=100&rft.epage=109&rft_id=info:doi/10.1016%2Fj.suronc.2015.04.003&rft.externalDBID=ECK1-s2.0-S0960740415000250&rft.externalDocID=1_s2_0_S0960740415000250 |
| thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F09607404%2FS0960740415X0003X%2Fcov150h.gif |